Drug Type Small molecule drug |
Synonyms 캐롤비코프플러스연질캡슐 |
Action inhibitors, antagonists, agonists |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (28 Nov 2025), |
Regulation- |
Molecular FormulaC17H20N4O6 |
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N |
CAS Registry83-88-5 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Common Cold | South Korea | 28 Nov 2025 |





